Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109)
- 5 November 2008
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 85 (2) , 182-189
- https://doi.org/10.1038/clpt.2008.201
Abstract
Thirty‐eight human immunodeficiency virus‐1 (HIV‐1)‐infected pregnant women were administered tenofovir disoproxil fumarate (TDF; 300 mg)–emtricitabine (FTC; 200 mg) tablets: two at labor initiation ...Keywords
This publication has 30 references indexed in Scilit:
- Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal‐cord plasma samplesBritish Journal of Clinical Pharmacology, 2007
- Variability in human hepatic MRP4 expression: influence of cholestasis and genotypeThe Pharmacogenomics Journal, 2007
- Mechanism of Active Renal Tubular Efflux of TenofovirAntimicrobial Agents and Chemotherapy, 2006
- Ontogeny of drug elimination by the human kidneyPediatric Nephrology, 2005
- Tenofovir Disoproxil FumarateDrugs, 2005
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Pharmacokinetic Changes During Pregnancy and Their Clinical RelevanceClinical Pharmacokinetics, 1997
- R: A Language for Data Analysis and GraphicsJournal of Computational and Graphical Statistics, 1996
- Drug disposition and pharmacokinetics in the maternal-placental-fetal unitPharmacology & Therapeutics, 1980
- TRANSIT TIME IN THE SMALL INTESTINE IN PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1970